Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Acupuncture Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Multiple Myeloma 5 Squamous Cell Carcinoma of Head and Neck 2 Peripheral Nervous System Diseases 2 Oropharyngeal Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Vomiting 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Hyperplasia 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Neoplasms 1 Myasthenia Gravis 1 Mucositis 1 Lymphoma, Follicular 1 Lymphedema 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Esthesioneuroblastoma, Olfactory 1 Esophageal Neoplasms 1 Deglutition Disorders 1

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡